PharmaBoehringer Ingelheim's Elena Livshina Finds Purpose in Tackling Cardiovascular Inequities
The company's US head for the cardiovascular portfolio is leading the effort to find new treatments for women living with...
TechnologyMulti-State Pilot to Test the Value of RPM for Methadone Treatment
The University of Washington School of Medicine and Scene Health are continuing a federally funded project that uses video-based remote...
TechnologyDEA Schedules Listening Sessions to Discuss Telemedicine Prescriptions
The agency will meet in September with interested parties to discuss a long-debated proposed registration for providers wishing to prescribe...
PharmaFerring Pharmaceuticals CSO is Invested in Improving Women's Healthcare
Born and raised in Nigeria, Elizabeth Garner understands the disparities in healthcare access and treatment and is seeking to level...
Revenue CycleInefficient 340B Payment Program Needs Stability and Oversight, Senate Says
Multiple senators recently sent a letter to stakeholders to seek input on improving the 340B drug pricing program.
PharmaCancerVax CEO Sees a Home Run With Breakthrough Universal Cancer Vaccine
Ryan Davies' career has been defined by taking risks. His newest company is taking on one of healthcare's biggest challenges.
PayerBuprenorphine Battles Reveal Mixed Results
Pushback on DEA regulations is measured by medication coverage trends that are improving but still lag in many areas.
TechnologyBreaking: DEA to Again Revise Telemedicine Prescribing Guidelines
Reacting to a wave of complaints against its earlier proposed revision of rules for prescribing controlled substances via telemedicine, the...
TechnologyHow Providers Should Use Technology to Meet the EPCS Mandate
Digital health tools that allow providers to electronically prescribe controlled medications can improve care management and curb drug misuse if...
Revenue Cycle5 Demands From the AHA to HHS on Recent 340B Ruling
The district court recently remanded remedy decisions to HHS for its underpayments related to the 340B drug pricing program.
Revenue CycleHow The 340B Payment Drama Defined Revenue Cycle in 2022
The 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and other covered entities at significantly...